Terms: = Lymphoma AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Treatment
12 results:
1. Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.
Miyagaki T; Inoue N; Kamijo H; Boki H; Takahashi-Shishido N; Suga H; Shimauchi T; Kiyohara E; Hirai Y; Yonekura K; Takeuchi K; Sugaya M
Br J Dermatol; 2023 Oct; 189(5):612-620. PubMed ID: 37539944
[TBL] [Abstract] [Full Text] [Related]
2. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
3. [Sequential development of mantle cell lymphoma following chronic lymphocytic leukemia].
Saga T; Ishihara T; Ito M; Kano S; Kanagawa M
Rinsho Ketsueki; 2020; 61(3):251-256. PubMed ID: 32224586
[TBL] [Abstract] [Full Text] [Related]
4. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of lymphoid enhancer-binding factor-1 (lef1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract] [Full Text] [Related]
6. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract] [Full Text] [Related]
7. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia.
Fu Y; Zhu H; Wu W; Xu J; Chen T; Xu B; Qian S; Li J; Liu P
Leuk Lymphoma; 2014 Feb; 55(2):371-7. PubMed ID: 23713453
[TBL] [Abstract] [Full Text] [Related]
9. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
[TBL] [Abstract] [Full Text] [Related]
10. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype.
Joosten M; Seitz V; Zimmermann K; Sommerfeld A; Berg E; Lenze D; Leser U; Stein H; Hummel M
Haematologica; 2013 Feb; 98(2):247-54. PubMed ID: 22899583
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of lef1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.
Kühnl A; Gökbuget N; Kaiser M; Schlee C; Stroux A; Burmeister T; Mochmann LH; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood; 2011 Dec; 118(24):6362-7. PubMed ID: 22010100
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
[TBL] [Abstract] [Full Text] [Related]
